The aim of this study was to evaluate the long-term efficacy and safety of clozapine in patients with treatment-resistant schizophrenia, schizoaffective disorder, or bipolar disorder with psychotic features.
Clozapine in treatment-resistant patients with schizophrenia, schizoaffective, and psychotic bipolar disorder: a naturalistic 48-month follow-up study
2003
Abstract
The aim of this study was to evaluate the long-term efficacy and safety of clozapine in patients with treatment-resistant schizophrenia, schizoaffective disorder, or bipolar disorder with psychotic features.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
prod_43712-doc_123122.pdf
non disponibili
Descrizione: Clozapine in treatment-resistant patients with schizophrenia, schizoaffective, and psychotic bipolar disorder: a naturalistic 48-month follow-up study
Tipologia:
Versione Editoriale (PDF)
Dimensione
54.16 kB
Formato
Adobe PDF
|
54.16 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
